Progression in disability and regional grey matter atrophy in relapsing

Abstract

Background:

In multiple sclerosis (MS) regional grey matter (GM) atrophy has been associated with disability progression.

Objective:

The aim of this study was to compare regional GM volume changes in relapsing–remitting MS (RRMS) patients with progressive and stable disability, using voxel-based morphometry (VBM).

Methods:

We acquired baseline and 1-year follow-up 3-dimensional (3D) T1-weighted magnetic resonance imaging (MRI) data of RRMS patients, using two 1.5-Tesla scanners. Patients were matched pair-wise with respect to age, gender, disease duration, medication, scanner and baseline Expanded Disability Status Scale (EDSS) into 13 pairs, with either progressive EDSS (≥ 1 point change y^-1) or stable EDSS, as well as into 29 pairs with either progressive Multiple Sclerosis Functional Composite (MSFC) at ≥ 0.25% decrease in y^-1 in any component, or stable MSFC. We analysed longitudinal regional differences in GM volumes in the progressive and stable EDSS and MSFC groups, respectively, using VBM.

Results:

Significant GM volume reductions occurred in the right precuneus, in the progressive EDSS group. Differential between-group effects occurred in the right precuneus and in the postcentral gyrus. Further longitudinal GM volume reductions occurred in the right orbicular gyrus, in the progressive MSFC group, but no between-group differences were observed (non-stationary cluster-wise inference, all P_corrected < 0.05).

Conclusion:

These results suggested a direct association of disability progression and regional GM atrophy in RRMS.

Keywords

Disability Expanded Disability Status Scale grey matter atrophy magnetic resonance imaging multiple sclerosis Multiple Sclerosis Functional Composite precuneus relapsing–remitting multiple sclerosis voxel-based morphometry

Get full access to this article

View all access options for this article.

References

Miller

Barkhof

Frank

. Measurement of atrophy in multiple sclerosis: Pathological basis, methodological aspects and clinical relevance. Brain 2002; 125: 1676–1695.

De Stefano

Matthews

Filippi

. Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability. Neurology 2003; 60: 1157–1162.

Sailer

Fischl

Salat

. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 2003; 126: 1734–1744.

Chard

Griffin

Rashid

. Progressive grey matter atrophy in clinically early relapsing–remitting multiple sclerosis. Mult Scler J 2004; 10: 387–391.

Charil

Dagher

Lerch

. Focal cortical atrophy in multiple sclerosis: Relation to lesion load and disability. Neuroimage 2007; 34: 509–517.

Bendfeldt

Kuster

Traud

. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study. Neuroimage 2009; 45: 60–67.

Pagani

Rocca

Gallo

. Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. Am J Neuroradiol 2005; 26: 341–346.

Audoin

Davies

Finisku

. Localization of grey matter atrophy in early RRMS: A longitudinal study. J Neurol 2006; 253: 1495–1501.

Calabrese

Rocca

Atzori

. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 67: 376–383.

10.

Chen

Narayanan

Collins

. Relating neocortical pathology to disability progression in multiple sclerosis using MRI. Neuroimage 2004; 23: 1168–1175.

11.

Rudick

Lee

Nakamura

. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. J Neurol Sci 2009; 282: 106–111.

12.

Fisher

Lee

Nakamura

. Gray matter atrophy in multiple sclerosis: A longitudinal study. Ann Neurol 2008; 64: 255–265.

13.

Jasperse

Vrenken

Sanz-Arigita

. Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis. Neuroimage 2007; 38: 529–537.

14.

Cohen

Reingold

Polman

. Disability outcome measures in multiple sclerosis clinical trials: Current status and future prospects. Lancet Neurol 2012; 11: 467–476.

15.

Ashburner

Friston

. Voxel-based morphometry - The methods. Neuroimage 2000; 11: 805–821.

16.

Good

Johnsrude

Ashburner

. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 21–36.

17.

Bakshi

Benedict

Bermel

. Regional brain atrophy is associated with physical disability in multiple sclerosis: Semiquantitative magnetic resonance imaging and relationship to clinical findings. J Neuroimag 2001; 11: 129–136.

18.

Polman

Reingold

Edan

. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol 2005; 58: 840–846.

19.

Bendfeldt

Hofstetter

Kuster

. Longitudinal gray matter changes in multiple sclerosis - Differential scanner and overall disease-related effects. Hum Brain Mapp 2012; 33: 1225–1245.

20.

Penner

Stemper

Calabrese

. Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis. Mult Scler J 2012; 18: 1466–1471.

21.

Kappos

Radue

O’Connor

. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2006; 362: 387–401.

22.

Chard

Griffin

Parker

. Brain atrophy in clinically early relapsing–remitting multiple sclerosis. Brain 2002; 125: 327–337.

23.

Kincses

Ropele

Jenkinson

. Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis. Mult Scler J 2011; 17: 681–689.

24.

Barkhof

. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002; 15: 239–245.

25.

Fisher

Rudick

Simon

. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002; 59: 1412–1420.

26.

Pellicano

Gallo

. Relationship of cortical atrophy to fatigue in patients with multiple sclerosis. Arch Neurol 2010; 67: 447–453.

27.

Calabrese

Rinaldi

Grossi

. Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing–remitting multiple sclerosis. Mult Scler J 2010; 16: 1220–1228.

28.

Riccitelli

Rocca

Forn

. Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue. Am J Neuroradiol 2011; 32: 874–879.

29.

Morgen

Sammer

Courtney

. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing–remitting MS. Neuroimage 2006; 30: 891–898.

30.

Tekok-Kilic

Benedict

Weinstock-Guttman

. Independent contributions of cortical gray matter atrophy and ventricle enlargment of predicting neuropsychological impairment in multiple sclerosis. Neuroimage 2007; 36: 1294–1300.

31.

Cohen

Neema

Arora

. The relationships among MRI-defined spinal cord involvement, brain involvement and disability in multiple sclerosis. J Neuroimaging 2012; 22: 122–128.

32.

Bonati

Fisniku

Altmann

. Cervical cord and brain grey matter atrophy independently associate with long-term MS disability. J Neurol Neurosurg Psychiatry 2011; 82: 471–472.

33.

Filippi

Rovaris

Inglese

. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 1489–1496.

34.

Barkhof

Calabresi

Miller

. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 2009; 5: 256–266.

35.

Sowell

Peterson

Kan

. Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age. Cereb Cortex 2007; 17: 1550–1560.

36.

Polman

Rudick

. The multiple sclerosis functional composite: A clinically meaningful measure of disability. Neurology 2010; 74: S8–15.

Progression in disability and regional grey matter atrophy in relapsing–remitting multiple sclerosis

Abstract

Background:

Objective:

Methods:

Results:

Conclusion:

Keywords

Get full access to this article

References